INTRODUCTION
============

Asparagine-linked glycosylation is a prominent protein modification reaction for proteins in eukaryotic cells. The enzyme oligosaccharyltransferase (OST) transfers a preassembled high-mannose oligosaccharide onto acceptor sites (NXT/S/C where X ≠ P) in nascent polypeptides that enter the lumen of the endoplasmic reticulum. The yeast OST is a heterooctamer composed of an active-site subunit (STT3) plus seven accessory subunits ([@B30]). Full activity of the yeast OST requires an oxidoreductase subunit (either Ost3p or Ost6p), which has been proposed to delay protein folding of segments in the vicinity of glycosylation acceptor sites ([@B50]; [@B51]; [@B42]). Most metazoan organisms express two OST complexes, which are composed of an active-site subunit (STT3A or STT3B), six shared subunits, and complex-specific accessory subunits ([@B13]; [@B56]). Phylogenetic analysis of metazoan and fungal STT3 proteins indicates that fungal STT3 proteins are more closely related to the STT3B clade than to the STT3A clade of metazoan STT3 proteins ([@B61]). Either MagT1 or TUSC3, which are orthologues of yeast Ost3p/Ost6p, is incorporated into the mammalian STT3B complex ([@B13]). Thus, from an evolutionary and composition standpoint, the yeast OST is equivalent to the mammalian STT3B complex.

N-linked glycosylation is typically viewed as a cotranslational reaction in mammalian cells, as there is abundant evidence that N-linked glycans are added in a synchronized manner to the elongating nascent chain ([@B47]; [@B8]) when the acceptor site is roughly 65--70 residues from the peptidyltransferase site on the ribosome ([@B71]; [@B36]; [@B17]). Insight into the coupling between protein translocation and N-linked glycosylation was provided by the discovery that the STT3A complex includes accessory subunits (DC2 and KCP2) that mediate a direct interaction between the STT3A complex and the protein translocation channel ([@B56]; [@B5]). *DC2*(--/--) HEK293 cells assemble a catalytically active STT3A complex that lacks DC2 and KCP2. The DC2/KCP2 deficient STT3A complex does not interact with the Sec61 complex and is unable to glycosylate STT3A-dependent acceptor sites ([@B56]). The mammalian STT3B complex, which does not interact with the protein translocation channel in the presence or absence of the STT3A complex ([@B56]; [@B5]), can mediate cotranslational or posttranslocational glycosylation of a subset of acceptor sites that have been skipped by STT3A ([@B48]; [@B61]).

High-resolution structures of the yeast OST obtained by cryo--electron microscopy ([@B1]; [@B72]) indicate that Ost3p is located in the same position that is occupied by DC2 in the mammalian STT3A complex ([@B5]). This shared location led to the hypothesis that Ost3p or Ost6p positions the yeast OST adjacent to the protein translocation channel ([@B1]). However, yeast has three protein translocation channels with different subunit compositions and different roles in protein translocation. The heterotrimeric Sec61 and Ssh1 complexes are involved in cotranslational translocation of proteins that are targeted to the ER membrane by the SRP--SRP receptor-targeting pathway ([@B19]; [@B35]; [@B27]). The heptameric Sec complex, which is composed of the heterotetrameric Sec62/Sec63 complex plus the Sec61 complex, is involved in posttranslational translocation of proteins with less hydrophobic signal sequences ([@B37]; [@B35]; [@B41]).

The split-ubiquitin system has been used to investigate potential interactions between yeast OST subunits and the Sec61p, Sbh1p, and Sss1p subunits of the Sec61 heterotrimer ([@B49]; [@B7]). However, the high-resolution structure of the yeast OST ([@B1]; [@B72]) is incompatible with the conclusions of these earlier studies ([@B7]) based on the location of the tagging sites relative to the membrane surface. For example, the tagging sites on Swp1p and Wbp1p are more than 60 Å away from the surface of the yeast OST (Ost3p) that has been proposed to interact with the Sec61 complex ([@B1]). One possible explanation for the multiple contacts between the Sec61 subunits and OST subunits that were observed with the split ubiquitin assay is that the interactions occurred during membrane integration of the OST subunits by the Sec61 complex. It was also proposed that OST complexes containing Ost3p interact with the Sec61 complex via Sbh1p, while OST complexes containing Ost6p interact with the Ssh1 complex via Sbh2p ([@B75]). However, the ubiquitin tags appended to Ost3p, Ost6p, Sbh1p, and Sbh2p were actually attached to lumenal C-terminal segments; hence, the split ubiquitin interactions that were sensed in the cytosol were generated from unassembled or misfolded protein subunits. Using correctly designed split ubiquitin constructs ([@B49]), the Römisch lab detected an interaction between the N-terminal amphipathic helix of Sss1p and the C-terminal cytoplasmic segment of Wbp1p. Examination of the yeast OST structure ([@B72]) reveals that the C-terminus of Wbp1p is located more than 60 Å from the closest cytoplasmically exposed segment of Ost3p; thus the putative Wbp1p-Sss1p interaction would localize the OST on the opposite side of the Sec61 heterotrimer, with the acceptor peptide--binding pocket in Stt3p facing away from the lateral gate of the Sec61 complex. For these reasons, we believe that the previous studies, which reported interactions between the yeast OST and protein translocation channels, are largely inconsistent with the subsequently determined structures of protein translocation channels and the oligosaccharyltransferase. Isolation of complexes that contain the yeast OST, a translocation channel, and a ribosome-nascent chain complex for cryo--electron microscopy analysis has also proven to be elusive despite attempts to assemble these complexes from purified components ([@B22]).

The structural homology between the yeast OST and the STT3B complex raises the possibility that N-linked glycosylation in yeast occurs by a mechanism that does not involve direct interactions between the OST and the three yeast protein--translocation channels. To address this possibility, we first compared glycosylation of several proteins in HEK293 cells and yeast to determine whether the yeast OST can glycosylate previously established STT3A-dependent or STT3B-dependent acceptor sites. Second, we used pulse--chase-­labeling procedures to determine whether posttranslocational N-glycosylation can be detected in yeast cells. Third, we solubilized yeast cell extracts to determine whether the yeast OST complex is associated with ribosome bound--protein translocation channels. All three lines of evidence led to the conclusion that protein translocation and N-glycosylation of polypeptides are uncoupled reactions in the yeast endoplasmic reticulum.

RESULTS
=======

Sec63p and DC2 bind to the same surface of Sec61p and Sec61α
------------------------------------------------------------

The recently solved structures of the yeast heptameric Sec complex ([@B24]; [@B74]) have well-resolved density for the Sec61 heterotrimer, Sec63p, Sec71p, and Sec72p ([Figure 1A](#F1){ref-type="fig"}). The three transmembrane (TM) spans of Sec63 (cyan helices) pack against the TM1 and TM5 of Sec61p and against the single TM spans of the β (Sbh1p) and γ (Sss1p) subunits of the Sec61 heterotrimer ([Figure 1B](#F1){ref-type="fig"}). Importantly, this is precisely the same surface as that of the mammalian Sec61 heterotrimer that interacts with the DC2 protein to promote interaction between the Sec61 heterotrimer and the STT3A complex ([Figure 1C](#F1){ref-type="fig"}). Similarly to Sec63p, TM3 of DC2 contacts TM1 of Sec61α and the C-terminal membrane--­embedded regions of Sec61β and Sec61γ, while TM1 of DC2 contacts TM5 of Sec61α. The orientation of Sec63 (3TM N~lum~-C~cyt~) is the opposite of DC2 (3TM N~cyt~-C~lum~), and TM2 of Sec63p and DC2 occupy nonoverlapping positions.

![Comparison of the Sec63p and DC2 binding sites on the yeast and mammalian Sec61 complexes. (A) Structure of the yeast Sec complex. Sec61p is raspberry, Sbh1p is marine, Sss1 is magenta, Sec63p is cyan, Sec71p is green, and Sec72p is blue. (B) Enlarged view of the interactions between the three TMs of Sec63p and the Sec61 heterotrimer, using the same color code as in panel A. The cytoplasmic domains of Sec63p, Sec71p, and Sec72p have been removed for clarity. The cytosolic (L1/2) and lumenal (L2/3) loops of Sec63p were not completely resolved. (C) Interaction between DC2 (yellow) and the mammalian Sec61 heterotrimer (color codes as in A). The other OST subunits are omitted for clarity, as the STT3A protein binds to the opposite face of DC2 from the Sec61 complex. (D) Space-filling model showing the interaction surface of DC2 and the TM spans of Sec61β, Sec61γ, and TM1 of Sec61α. Proteins are color-coded as in C. Residues in the Sec61 complex that compose the interaction surface (K29 and L33 in Sec61α, F53, L56, P60, and N63 in Sec61γ, and S96 in Sec61β) are color-coded by element and are labeled. (E) DC2-Sec61 complex interaction surface color-coded as in D. (F) Space-filling model of the interface between Sec63p (cyan; TM1, TM3, and the resolved section of L2), Sss1p (magenta), Sbh1p (slate), and TM1 of Sec1p (raspberry). The residues in the yeast Sec61 complex subunits that align with residues shown in panels D and E (Supplemental Table S1) are color-coded by element and are labeled. P74 and Y77 in Sss1p are completely buried by Sec63p, while other interaction residues are partially buried. The figure was made with PYMOL v2.1 software and PDB files 6N3Q (A, B, F) and 6FTI (C--E).](mbc-30-2626-g001){#F1}

For a more detailed analysis of the interaction surfaces, we identified residues in Sec61α, Sec61β, and Sec61γ that define the binding surface for DC2 ([Figure 1, D and E](#F1){ref-type="fig"}; Supplemental Table S1). On the basis of sequence alignments of yeast and mammalian Sec61 complex subunits, we asked whether the corresponding residues in Sec61p, Sbh1p, and Sss1p were surface- exposed in the Sec complex, or were instead providing the binding site for Sec63p. As shown in [Figure 1F](#F1){ref-type="fig"}, five of the six aligned yeast residues are either partially or fully buried by Sec63 in the Sec complex. TM2 of Sec63, which is not shown in [Figure 1F](#F1){ref-type="fig"} for clarity, would sterically block Ost3p from contacting the remaining residue of Sec61γ (A67) that does not directly contact Sec63p. Thus, the potential Ost3p interaction surface in the Sec complex is occluded by Sec63p.

The yeast secretome lacks cysteine-rich glycoproteins
-----------------------------------------------------

Cotranslational glycosylation of human proteins by the translocation channel--associated STT3A complex is important for glycosylation of sequons that are located in cysteine-rich protein domains ([@B14]). To determine whether there are cysteine-rich yeast glycoproteins, we compiled a list of yeast N-glycosylation sites by merging four databases from glycoproteomics studies that utilized different glycopeptide enrichment or detection procedures ([@B76]; [@B9],[@B10]). The glycoproteomics studies utilized N-glycanase--dependent deamidation of lectin-enriched glycopeptides ([@B76]), chemical (TMSF)- or enzymatic (Endo H)-dependent generation of GlcNAc-modified peptides ([@B10]), or N-glycanase--dependent deamidation of boronic acid--enriched glycopeptides ([@B9]). Owing to the variety of methods used to enrich and detect N-­glycopeptides, a combined data set should have excellent coverage of the yeast N-glycoproteome. From each data set, we excluded peptides that lack a canonical sequon (N-X-T/S/C; X ≠ P), as such sites, if modified in human cells, show very low occupancy ([@B69]). We also excluded peptides that are derived from proteins that do not contain a signal sequence or a transmembrane span, using a yeast secretome database as a resource (Supplemental Table S5 from [@B26]). In ambiguous cases where an ER targeting signal may have been overlooked, protein sequences were also analyzed using the SignalP 4.1 server ([@B38]) to detect signal sequences and the ΔG prediction server for TM span identification ([@B23]). Peptides derived from carboxy-terminal tail-anchored (TA) membrane proteins were excluded, as the putative glycopeptides are located in the cytosol. After merger of the four data sets, we obtained a list of 830 experimentally detected acceptor sites, roughly 60% of which were present in at least two data sets ([Figure 2A](#F2){ref-type="fig"} \[overlap\]; Supplemental Table S2A). It should be noted that the merged data set is not a complete list of verified yeast glycosylation sites, as we have not attempted to augment Supplemental Table S2A by including acceptor sites that have been identified by nonglycoproteomics methods. For example, only two of the four known glycosylation sites in carboxypeptidase Y (CPY, *PRC1* gene) were detected by LC-MS/MS (Supplemental Table S2A). The 830 N-linked glycosylation sites are derived from 251 yeast proteins (Supplemental Table S2B). Roughly 17% of the yeast secretome proteins included in Supplemental Table S2B are based on a single glycopeptide that was present in only one of the four data sets. Although the glycoprotein list may well include false positives, we did not want to overlook any cysteine-rich yeast glycoproteins. The 251 proteins have an average cysteine content of 1.3%, with no protein having a cysteine content that exceeds 3.5% ([Figure 2B](#F2){ref-type="fig"}). Labeled arrows indicate the cysteine content of several yeast glycoproteins that have been used to evaluate N-glycosylation in previous studies ([@B44]; [@B63]; [@B42]).

![The yeast secretome does not contain cysteine-rich glycoproteins. (A) Yeast glycosylation sites were identified in the following mass spectrometry studies: data set 1, Class 1 sites, Supplemental Table S2 from [@B76]; data set 2, Supplemental Table S1 from [@B10]; data set 3, Supplemental Table S2 from [@B10]; data set 4, Supplemental Table S3 from [@B9]. Data sets were trimmed by excluding sites that did not match a consensus glycosylation site (NXT/S/C) or were derived from nonsecretome proteins. The data sets were merged to obtain 830 glycosylation sites that were present in one to four of the initial data sets, as indicated in the overlap column. The 830 glycosylation sites were derived from 251 yeast secretome proteins. (B) The distribution of cysteine content in 251 yeast glycoproteins. The cysteine content of several glycoproteins is indicated by labeled arrows. (C) The distribution of cysteine content in a collection of 892 human glycoproteins ([@B14]). The cysteine content of an STT3B-dependent (SHBG) and two STT3A-dependent (SAP and GRAN) substrates is indicated by labeled arrows.](mbc-30-2626-g002){#F2}

The cysteine content of a collection of 892 HEK293 cell glycoproteins with experimentally verified glycosylation sites ([@B14]) was also determined ([Figure 2C](#F2){ref-type="fig"}; Supplemental Table S2C). The average cysteine content of the human proteins was twofold higher (2.7%), with 21.5% of the proteins having a cysteine content that was higher than those of all yeast glycoproteins. Prosaposin (SAP) and granulin (GRAN) are cysteine-rich proteins that are STT3A-dependent substrates ([@B48]; [@B60]). We conclude that yeast lacks cysteine-rich glycoproteins.

Hypoglycosylation of prosaposin in yeast
----------------------------------------

Prosaposin is a cysteine-rich mammalian glycoprotein that contains five acceptor sites that are located in 80-residue cysteine-rich protein domains. Synthesis of prosaposin in STT3A(--/--) cells yields prosaposin glycoforms having on average two glycans ([@B12]; [@B56]). A SILAC-based quantitative glycoproteomics analysis of *STT3A(--/--)* and *STT3B(--/--)* cells yielded glycosylation-site occupancy data for roughly 1000 N-X-T/S/C, sites including all five prosaposin sites ([@B14]). Of the five sites in prosaposin, glycosylation of three acceptor sites was reduced four- to eightfold, and one site was reduced roughly 2.5-fold, while glycosylation of the N~215~ST site was not reduced in the *STT3A(--/--)* cell line ([Figure 3A](#F3){ref-type="fig"}).

![Glycosylation of human prosaposin in yeast and human cells. (A) SILAC-based glycoproteomic analysis of prosaposin glycosylation in HEK293-derived cells that lack either the STT3A or STT3B complex. Site occupancy is expressed as Δlog~2~, where a negative value indicates reduced glycosylation in the mutant cells relative to the wild-type cells. Error bars designate standard deviations (*n* = 3--7) or individual data points (\*, *n* = 2). (B) Signal sequences for wild-type CPY and a more hydrophobic derivative (CPY+4). The underlined leucine residues in CPY+4 replace marginally hydrophobic amino acids. The diagonal line designates the signal sequence cleavage site. (C) CPY and pSAP constructs that have the CPY signal sequence or the CPY+4 signal sequence were pulse-labeled for 7 min with Tran-^35^S label in wild-type yeast cells. (D) Diagrams of the SAP, SAPΔ3,5, and SAPΔ1,2,4 constructs for expression of prosaposin derivatives in yeast and human cells. The signal sequences for human prosaposin (SAP~ss~) and yeast CPY (CPY~ss~) are for expression in HEK293 cells and yeast, respectively. Saposin domains are designated by cyan rectangles. Red lines designate disulfides. The disulfide bonding pattern of the N-terminal and C-terminal flanking domains is not known. A C-terminal DDK-His tag was appended for immunoprecipitation with anti-DDK sera. (E) Pulse labeling (10 min) of pSAP, pSAPΔ1,2,4, and pSAPΔ3,5 in wild-type and STT3A-deficient HEK293 cells. (F) Pulse labeling (7 min) of SAP, SAPΔ3,5, and SAPΔ1,2,4 in yeast. (G) Pulse--chase labeling of CPYss-SAP (Δ1,2,4) in yeast using the indicated pulse (P) and chase (C) intervals. (F, G) Quantified values are of the experiment shown, which is representative of two or more replicates. In C and E--G, labeled arrows indicate the number of glycans. EH indicates digestion with endoglycosidase H.](mbc-30-2626-g003){#F3}

Yeast proteins that are cotranslationally translocated by the Sec61 or Ssh1 heterotrimers have more hydrophobic signal sequences than carboxypeptidase Y (CPY), which is translocated via the heptameric Sec complex ([@B35]). Replacement of four weakly hydrophobic residues in the CPY signal sequence with leucine residues yielded the CPY~+4~ signal sequence ([Figure 3B](#F3){ref-type="fig"}). The calculated ΔG~app~ values ([@B23]) indicate that the CPY~+4~ signal sequence has a hydrophobicity comparable to that of the TM spans of the proteins (DPAPB and Pho8), which are cotranslationally integrated in yeast cells ([@B35]). Previously we showed that the CPY~+4~ protein is cotranslationally translocated by the Sec61 complex or the Ssh1 complex ([@B68]).

Translocation of CPY into the ER lumen is accompanied by cleavage of the N-terminal signal sequence and by the addition of four N-linked glycans to yield the ER (p1) form of CPY. Mannosylation of the N-linked glycans in the Golgi yields the p2 form of CPY, which migrates slightly more slowly than p1CPY when resolved by SDS--PAGE. Proteolytic removal of the propeptide in the vacuole yields mature CPY. When yeast cells are pulse-labeled for 7 min, p1-CPY is the major form of CPY that is resolved by SDS--PAGE ([@B11]; [@B27]; [@B68]), though p2CPY was detected as a faint band ([Figure 3C](#F3){ref-type="fig"}). Endoglycosidase H (EH) digestion of p1CPY removes the N-linked glycans, demonstrating that the predominant form of p1CPY has four N-linked glycans, as expected ([Figure 3C](#F3){ref-type="fig"}). The signal sequence and the protein translocation channel had no impact upon N-glycosylation of CPY ([Figure 3C](#F3){ref-type="fig"}).

To investigate glycosylation of prosaposin in yeast, we replaced the prosaposin signal sequence with the CPY or CPY~+4~ signal sequence and expressed the CPY~ss~-SAP and CPY~+4~-SAP constructs under control of the glyceraldehyde 3-phosphate (GPD) promoter in a wild-type yeast strain. A pulse-labeling experiment revealed prosaposin glycoforms containing one to three glycans, with the two-glycan form being most abundant ([Figure 3C](#F3){ref-type="fig"}). Glycosylation of prosaposin in yeast was not affected by the targeting pathway or the protein translocation channel. Thus, occupation of the potential Ost3p binding site in the yeast Sec complex by Sec63p does not reduce glycosylation of CPY or prosaposin when these proteins are translocated via the Sec complex.

On the basis of the mass spectrometry results ([Figure 3A](#F3){ref-type="fig"}), we designed two prosaposin reporters, one of which includes the three sites that are more dependent on STT3A (pSAP Δ3,5), while a second reporter (pSAP Δ1,2,4) contained the two sites that are less dependent on STT3A ([Figure 3D](#F3){ref-type="fig"}). Our objective was to determine whether the same prosaposin sites that are hypoglycosylated in STT3A-deficient human cells are the pSAP sites that are poorly glycosylated in yeast cells. The pSAP Δ1,2,4 and pSAP Δ3,5 reporters were characterized by expressing them in wild-type and *STT3A*(--/--) HEK293 cells ([Figure 3E](#F3){ref-type="fig"}). Glycosylation of pSAP and of pSAP Δ1,2,4 were quite similar in the *STT3A*(--/--) cell line, consistent with the mass spectrometry results. The pSAP Δ3,5 reporter is glycosylated in wild-type cells, but is very poorly glycosylated in *STT3A*(--/--) cells. When CPY~ss~-SAP, CPY~ss~-SAP Δ1,2,4, and CPY~ss~-SAP Δ3,5 were expressed in yeast, we detected prosaposin glycoforms that were remarkably similar to what we observed for the mammalian pSAP reporters in the STT3A-deficient cells (compare [Figure 3, E and F](#F3){ref-type="fig"}). The yeast OST is unable to glycosylate the three prosaposin sites that need to be cotranslationally glycosylated in human cells by the translocation channel--associated STT3A complex ([Figure 2F](#F2){ref-type="fig"}, CPY~ss~-SAP Δ3,5).

Owing to the oxidizing environment of the ER lumen, cysteine residues in translocated proteins begin to form native and nonnative disulfide bonds upon entry into the ER lumen. Oxidation of the cysteine residues in prosaposin is particularly rapid in mammalian cells. In less than 5 min, prosaposin becomes resistant to PEG-maleimide modification following pulse labeling ([@B48]); hence the four saposin domains quickly acquire a disulfide-­stabilized conformation. A pulse--chase-labeling experiment was conducted to determine whether the acceptor sites in the CPYss-pSAP Δ1,2,4 reporter could be fully glycosylated upon extended incubation ([Figure 3G](#F3){ref-type="fig"}). We did not detect any change in glycosylation during the chase interval, indicating that the incompletely modified site (presumably N~426~ST) is intractable to glycosylation by the end of the 4-min pulse-labeling period in yeast cells. Given the conservation of disulfide bond--formation pathways in eukaryotic cells ([@B52]; [@B6]) and the critical role of the protein sequence and secondary structural elements in the kinetics of protein folding, oxidation of prosaposin in the yeast ER should be rapid. Transport of disulfide-bonded proteins such as CPY from the ER to the Golgi is blocked when the ER lumen is reduced by DTT treatment ([@B25]); hence the rapid intracellular transport of CPY in untreated cells is diagnostic of rapid disulfide bond oxidation in the yeast ER. We propose that formation of disulfides in the yeast ER minimizes posttranslocational glycosylation of prosaposin by the yeast OST.

Posttranslocational glycosylation of sex hormone--binding in yeast
------------------------------------------------------------------

Sex hormone--binding globulin (SHBG) has two extreme C-terminal sites ([Figure 4A](#F4){ref-type="fig"}) that are posttranslocationally glycosylated by the STT3B complex in human cells ([@B61]; [@B12]). Here, we tested whether the yeast OST can glycosylate these STT3B-dependent acceptor sites. Incomplete glycosylation of the N~380~RS site is responsible for the glycoform doublet ([Figure 4B](#F4){ref-type="fig"}) that is detected in wild-type or *STT3A(--/--)* cells ([@B61]). A similar glycoform doublet was detected when CPY~ss~-SHBG was expressed in yeast cells ([Figure 4B](#F4){ref-type="fig"}), indicating that the yeast OST can glycosylate a human protein that has STT3B-dependent sites. In human cells, glycosylation of SHBG occurs by a posttranslocational mechanism, as shown by pulse--chase-labeling experiments ([@B61]). Pulse--chase-­labeling of SHBG in yeast cells revealed clear evidence for increased glycosylation of SHBG during the chase incubation ([Figure 4C](#F4){ref-type="fig"}). The yeast OST, unlike the human STT3A complex ([Figure 4B](#F4){ref-type="fig"}), can glycosylate acceptor sites after the completed protein has entered the ER lumen.

![Pulse labeling of SHBG in human and yeast cells. (A) Diagram of SHBG showing signal sequences for expression of SHBG in human and yeast cells, the location of disulfide bonds, and the C-terminal glycosylation sites. (B) Pulse--chase labeling of SHBG in wild-type and mutant HEK293 cells (left panel, 5 min pulse, 20 min chase). Pulse labeling of CPYss-SHBG for 8 min in yeast cells (right panel). (C) Pulse--chase labeling of CPYss-SHBG in yeast using the indicated pulse (P) and chase (C) intervals. In B and C, quantified values are of the experiment shown, which is representative of two replicates. EH indicates digestion with endoglycosidase H.](mbc-30-2626-g004){#F4}

Glycosylation of closely spaced acceptor sites
----------------------------------------------

N-terminal to C-terminal scanning of the nascent polypeptide for acceptor sites by the translocation channel--associated STT3A complex appears to be important for N-glycosylation of closely spaced acceptor sites in human cells ([@B57]). The STT3A complex can glycosylate certain NXT sites that are adjacent (e.g., NHTNAT), while NHS sites were incompletely modified unless separated by two (e.g., NHSAANAS) or more residues ([@B57]). To compare glycosylation of closely spaced sites in yeast and human cells, we introduced glycosylation sites into a CPY derivative that lacks the four sites present in wild-type CPY ([@B73]). The introduced glycosylation sites were positioned near the propeptide--mature CPY boundary, or roughly 80 residues from the C-terminus, as sets of either two or three NXT or NXS sites that are separated by two spacer residues ([Figure 5A](#F5){ref-type="fig"}). The CPY~+4~ signal sequence was used for expression in yeast, while the prosaposin signal sequence was used for expression in HEK293 cells. A wild-type CPY construct was also included to provide a marker for CPY with four glycans. When it was expressed in HEK293 cells, we detected a single glycan on the S12 and two glycans on the S123, S45, T45, S456, and T456 reporters. The T12 and T123 reporters yielded doublets, consistent with partial modification of two and three sites, respectively ([Figure 5B](#F5){ref-type="fig"}, downward-pointing arrowheads). Suboptimal flanking residues are preventing complete modification of one acceptor site in several constructs. In the case of the S456 and T456 acceptor sites, bioinformatic analysis indicates that a proline residue at the +3 position of a sequon is unfavorable but not forbidden ([@B20]). In vitro assays using proline containing synthetic peptides have shown that a proline residue at the +3 position reduces peptide glycosylation ([@B2]).

![Glycosylation of CPY derivatives in yeast and human cells. (A) Diagram of CPY derivatives with closely spaced acceptor sites. The wild-type signal sequence of CPY was replaced with either the prosaposin signal sequence (SAP~ss~) for expression in human cells or the CPY+4 sequence to direct cotranslational translocation in yeast. The four glycosylation sites in CPY were eliminated by the indicated N to Q mutations to create the SAPss-CPYΔ4 and CPY+4ss-CPYΔ4 constructs. Two or three closely spaced NXS or NXT sites were created at the indicated sites to yield eight reporters. The introduced glycosylation sites are underlined. (B) Pulse labeling of the SAP~ss~-CPY and SAP~ss~-CPYΔ4 derivatives in wild-type and *STT3A(--/--)* HEK293 cells. Downward-pointing arrowheads indicate the fully glycosylated form of the T12 and T123 reporters. Upward-pointing arrowheads indicate hypoglycosylated forms of S12 and S45 reporter that were detected in *STT3A(--/--)* cells. (C) Pulse labeling (4 min) of CPY+4~ss~-CPY and CPY+4~ss~-CPYΔ4 derivatives expressed in yeast. Upward-pointing arrowheads designate hypoglycosylated forms of the reporters that are either less abundant or not detected in wild-type HEK293 cells. Note the absence of the fully glycosylated T12 and T123 reporters. (D) Pulse--chase labeling of selected CPY+4~ss~-CPYΔ4 derivatives in yeast. The pulse period was 2 min for all samples. Upward-pointing arrowheads designate hypoglycosylated forms of NXS containing reporters that are more prominent before the chase period. The downward-pointing arrowheads designate trace amounts of the fully glycosylated T12 and T123 reporters that were visible after the chase. The quantified values below the gel lanes are for the experiment shown, which is representative of two similar experiments.](mbc-30-2626-g005){#F5}

Expression of the S12 and S45 constructs in STT3A-deficient cells yielded faster-­migrating products that lacked an additional glycan ([Figure 5B](#F5){ref-type="fig"}, upward-pointing arrowheads), highlighting the importance of a cotranslational mechanism for glycosylation of closely spaced sites. All of the reporters with NXS sites migrated as doublets when expressed in yeast, due to the incomplete modification of one of the sites ([Figure 5C](#F5){ref-type="fig"}, upward-pointing arrowheads). Notably, the glycoform doublets for the S12 and S45 reporters resembled the products synthesized in STT3A-deficient HEK293 cells. Fully glycosylated forms of the T12 and T123 reporters were absent when yeast cells were pulse-labeled for 4 min. Thus, all reporters except T45 and T456 were hypoglycosylated in yeast cells relative to HEK293 cells. The yeast OST has a reduced ability to glycosylate closely spaced acceptor sites compared with that of the STT3A complex.

A pulse--chase-labeling experiment using a shorter pulse period (2 min) was conducted to determine whether the acceptor sites in the CPY derivatives were being glycosylated by a strictly cotranslational mechanism ([Figure 5D](#F5){ref-type="fig"}). Although glycosylation of the CPY derivatives was rapid, we detected modest increases in glycan occupancy after the chase incubation. The glycoform doublets for the reporters with NXS sites were more pronounced after a 2-min pulse period ([Figure 5D](#F5){ref-type="fig"}, upward-pointing arrowheads) and diminished during the subsequent 6-min chase period. Traces of the fully glycosylated T12 and T123 reporters were also visible after the chase incubation ([Figure 4D](#F4){ref-type="fig"}, downward-pointing arrowheads). Slow glycosylation of these internal acceptor sites (e.g., S123) provides evidence that glycosylation of acceptor sites is not occurring by an N-- to C--terminal scanning mechanism as the nascent polypeptide passes through the protein translocation channel.

The yeast OST is not a ribosome-associated membrane protein
-----------------------------------------------------------

In an effort to detect OST complexes that interact with the Sec61 or Ssh1 heterotrimers, we used a ribosome-associated membrane protein (RAMP) isolation procedure ([Figure 6A](#F6){ref-type="fig"}) that had been developed to characterize the interaction between mammalian ER proteins and the Sec61 complex ([@B21]; [@B70]; [@B55]). Treatment of mammalian microsomes with the nonionic detergent digitonin in the presence of a physiological--ionic strength buffer dissolves the membrane, releasing complexes between translating ribosomes and the Sec61 protein translocation channel. The STT3A complex, but not the STT3B complex, is a prominent component in a RAMP preparation ([@B55]; [@B56]).

![The yeast OST does not cosediment with ribosome translocation channel complexes. (A) Microsomes isolated from RGY1455, which expresses His~6~-FLAG-Sbh2p, were used to prepare a RAMP fraction as outlined in the diagram. (B) The total membrane extract (T), the combined supernatant fraction (S = S1+W1+W2), and the pellet fraction (RAMP) were analyzed by protein immunoblot analysis using the indicated antisera. Sample loads for the three fractions were derived from equal amounts of yeast microsomes. Asterisks designate nonspecific immunoreactive products on the Wbp1 and Swp1p blots.](mbc-30-2626-g006){#F6}

Yeast microsomal membranes were subjected to the RAMP isolation procedure ([Figure 6A](#F6){ref-type="fig"}). Immunoblotting was used to detect proteins in the total detergent extract (T), the RAMP fraction (RAMP), and a supernatant fraction (S), which was obtained by combining the S1, W1, and W2 fractions. Ribosomes, as detected using antisera specific for a large ribosomal subunit protein (Rpl3p), and Ssh1 heterotrimers, as indicated by the Sbh2-HA immunoreactivity, were primarily recovered in the RAMP fraction ([Figure 6B](#F6){ref-type="fig"}). We used the Sbh2 subunit as the positive control for the RAMP isolation, as the Ssh1 complex is a cotranslational translocation channel ([@B27]) that binds ribosome--nascent chain complexes ([@B4]). Sec61p and Sbh1p would report on the Sec complex in addition to the RNC-associated Sec61 heterotrimer. Cosedimentation of Sbh2p (or Shb1p) with the ribosome is strictly dependent on evolutionarily conserved basic residues in cytoplasmic loop 8/9 of Ssh1p or Sec61p ([@B11]; [@B4]; [@B33]). The yeast Sec complex does not bind ribosomes ([@B43]) because cytosolic loop L6/7 in Sec61p is covered by the cytosolic domain of Sec63p ([Figure 1A](#F1){ref-type="fig"}). As expected, Sec63p was recovered in the supernatant fraction. The protein immunoblots were probed with antibodies to three of the yeast OST subunits (Ost1p, Wbp1p, and Swp1p). Ost1p migrates as a triplet containing two to four glycans due to incomplete N-glycosylation of the four acceptor sites in Ost1p ([@B29]; [@B63]). Ost1p was recovered exclusively in the supernatant fraction ([Figure 6B](#F6){ref-type="fig"}). Wbp1p and Sw1p were also recovered in the supernatant fractions, indicating that the yeast OST does not interact with Sec61 or Ssh1 heterotrimers with sufficient avidity to cosediment with ribosome nascent chain complexes.

Two previous publications provide additional evidence that the yeast OST does not form stable complexes with protein translocation channels. Blue native PAGE (BN-PAGE) of yeast microsomes has been used to resolve the yeast OST into two complexes that contain either Ost3p or Ost6p as a subunit ([@B64]). These yeast OST complexes have a mobility on BN-PAGE gels that is very similar to that of the mammalian STT3B complex (∼500 kDa) ([@B64]; [@B45]; [@B56]). The mammalian STT3A complex (∼470 kDa on BN-PAGE gels) is assembled into larger complexes that contain the Sec61 heterotrimer (∼700 kDa by BN-PAGE; [@B55]; [@B15]; [@B56]). The yeast OST is not present in larger complexes with a lower mobility on BN-PAGE gels ([@B64]). Native immunoprecipitation of the yeast OST from uniformly radiolabeled yeast microsomes using an epitope-tagged subunit (OST3-HA or STT3-HA) as the precipitating antigen provided evidence for 1:1 stoichiometry of the eight OST subunits, but did not disclose additional unidentified proteins that could be subunits of the protein translocation channel ([@B28]).

DISCUSSION
==========

Previous investigators have assumed that N-linked glycosylation is directly coupled to protein translocation in budding yeast, based on the view that a cotranslational scanning mechanism for protein glycosylation would be conserved between metazoa and fungi. The yeast proteins that have been used to monitor protein translocation reactions in yeast are N-linked glycoproteins including CPY, Gas1p, dipeptidylaminopeptidase B (DPAPB), and invertase (Suc2p; [@B35]; [@B67]). Typically, a 5- to 7-min pulse-­labeling interval is used to obtain sufficient radiolabeled protein for detection of the nonglycosylated cytoplasmic precursors and fully glycosylated translocated products. Hypoglycosylated glycoprotein variants are not typically detected in wild-type yeast, but are prominent products in strains bearing mutations in OST subunits ([@B66]; [@B63]). Thus, standard labeling procedures utilizing endogenous yeast glycoproteins as substrates had not revealed evidence for posttranslocational glycosylation. Here, we have been able to detect posttranslocational glycosylation in part due to the choice of substrates like SHBG, and in part due to utilizing shorter pulse-labeling intervals.

Hypoglycosylation of STT3A substrates by the yeast OST
------------------------------------------------------

In mammalian glycoproteins, the sequons that cannot be efficiently modified by the STT3B complex, such as those in prosaposin, are classified as being STT3A-dependent. Strikingly, glycosylation of prosaposin by the yeast OST was remarkably similar to glycosylation of prosaposin in STT3A-deficient human cells. We speculate that the difference in STT3A sensitivity of the acceptor sites in prosaposin is related to the folding kinetics of the individual saposin domains and the affinity of STT3B for the acceptor sites. Prosaposin contains a single NXS site (N~101~MS), so the observed differences in STT3A dependence are not explained simply by the preference of the OST for NXT sites relative to NXS sites.

Efficient glycosylation of closely spaced acceptor sites in human glycoproteins is facilitated by cotranslational scanning of the nascent protein by the translocation channel--associated STT3A complex ([@B57]). The CPY derivatives containing closely spaced acceptor sites were more prone to hypoglycosylation when expressed in yeast or in *STT3A*(--/--) cells, particularly when the reporters contained tandem NXS sites. The pulse--chase-labeling experiment conducted in yeast provided evidence for posttranslocational glycosylation of the closely spaced acceptor sites even when the sequons were located in the N-terminal half of the protein.

Posttranslocational glycosylation of extreme C-terminal glycosylation sites
---------------------------------------------------------------------------

Previously we had reported that murine glycoproteins contain a lower density of sequons and experimentally verified acceptor sites in the extreme C-terminal 70 residues of the protein ([@B61]). In contrast, yeast glycoproteins have a more uniform distribution of sequons and experimentally verified N-glycosylated acceptor sites ([@B61]). Here we observed that the yeast OST glycosylates SHBG, a previously established STT3B substrate, with an efficiency similar to that displayed by the human STT3B complex. Glycosylation of SHBG was incomplete after a brief pulse labeling period, but increased during the subsequent chase incubation, consistent with posttranslocational glycosylation. The rather slow but effective posttranslocational glycosylation of SHBG by the yeast OST contrasts markedly with the ineffective glycosylation of pSAP Δ3,5 and the rapidly achieved plateau value for glycosylation of pSAP Δ1,2,4. Thus, posttranslocational glycosylation of proteins by the yeast OST appears to be limited by the folding status of the polypeptide in the vicinity of the glycosylation site. The active-site disulfide in the oxidoreductase subunit (Ost3p or Ost6p) of the yeast OST is in the oxidized state in the cell ([@B51]), so formation of a mixed disulfide with a free thiol in a substrate is possible. As Ost3p and Ost6p lack a second active-site disulfide, they lack protein disulfide isomerase activity ([@B51]) and are not able to reduce preformed disulfides in cysteine-rich protein domains such as those in prosaposin.

N-glycosylation efficiency in yeast is not influenced by translocation channel identity
---------------------------------------------------------------------------------------

The identity of the translocation channel (Sec complex vs. Sec61 or Ssh1 heterotrimers) does not influence CPY or prosaposin glycosylation in yeast, indicating that a cotranslational scanning mechanism for N-glycosylation is not restricted to the heterotrimeric-protein translocation channels that retain the potential OST interaction site. We were unable to detect any interaction between the yeast OST and ribosome-bound translocation channels that persists after detergent solubilization of yeast microsomes. The distribution of incompletely modified sites in prosaposin and the closely spaced CPY reporters rules out the possibility that the OST is recruited to a translocation channel after the nascent polypeptide enters the ER lumen.

The yeast oligosaccharyltransferase lacks determinants that promote interactions with translocation channels
------------------------------------------------------------------------------------------------------------

DC2 and to a lesser extent KCP2 are the accessory subunits that promote interaction between the STT3A complex and the mammalian Sec61 complex ([@B56]). Eukaryotic organisms (e.g., *Saccharomyces cerevisiae*) that lack a gene encoding STT3A also lack the genes encoding DC2 and KCP2. OST3 and DC2 occupy identical positions in the yeast OST and the mammalian STT3A complex due to a shared binding surface on STT3 and STT3A, respectively. Moreover, DC2 and TM2-4 of Ost3p have a similar folded structure and are evolutionarily related, based on the presence of short blocks of sequence identity ([@B5]; [@B72]). A second interaction between the STT3A complex and the RNC-Sec61 complex is mediated by the C-terminal four-helix bundle of ribophorin I (RPN1), which contacts eL28, rRNA H25, and rRNA H19/20 on the large ribosomal subunit ([@B5]). Ost1p, the yeast orthologue of RPN1, lacks the cytoplasmic extension that forms this four-helix bundle ([@B63]). Consequently, the yeast OST lacks both of the binding surfaces that promote the interaction between the STT3A complex and the Sec61-RNC complex in mammalian cells.

Several papers relying on split-ubiquitin reporter constructs have reported interactions between subunits of the yeast Sec61 complex and the OST ([@B49]; [@B7]). While the putative interactions are structurally incompatible with the hypothesis that Ost3p mediates the interaction of the OST with the Sec61 heterotrimer ([@B1]), an alternative interaction surface remains a formal possibility. Cryo--electron tomographic analysis of yeast microsomes will be needed to resolve this issue, as such analysis has been very useful for detecting Sec61-associated protein complexes in the mammalian ER ([@B39], [@B40]; [@B5]).

The oxidoreductase subunits (Ost3p/Ost6p) have an N-terminal signal sequence, a lumenal thioredoxin domain, and four TM spans, so they adopt a 4TM N~lum~-C~lum~ topology, while DC2, which lacks a thioredoxin domain, has a 3TM N~cyt~-C~lum~ topology. As TM1 of Ost3p and the lumenal thioredoxin domain were not well resolved in the cryo--electron microscopy structures of the yeast OST ([@B1]; [@B72]), it is likely that the thioredoxin domain can adopt several conformations with respect to STT3. We have proposed that TM1 and the thioredoxin domain of Ost3p (or Ost6p) act as negative determinants to prevent the interaction between the Sec61 complex and the yeast OST ([@B59]). The STT3B complex, which also contains an oxidoreductase subunit (MagT1 or TUSC3), does not interact with the Sec61-RNC complex in STT3A-deficient human cells ([@B56]; [@B5]).

STT3 duplication and glycoproteome expansion
--------------------------------------------

The 830 glycosylation sites listed in Supplemental Table S2A can be viewed as a lower limit for the total number of yeast glycosylation sites. Nonetheless, it is clear from previous glycoproteomics analysis of model organisms that fungal glycoproteomes (*S. cerevisiae* and *Schizosaccharomyces pombe*) are considerably smaller than metazoan glycoproteomes ([@B77], [@B76]). Below, we present a rationale for why the duplication of the OST active site subunit (STT3) to give rise to the STT3A and STT3B complexes is one factor that allowed glycoproteome expansion.

Prosaposin, which was the first identified STT3A-dependent substrate ([@B48]), is an example of a cysteine-rich glycoprotein that contains relatively small cysteine-rich domains. Quantitative glycoproteomic analysis of STT3A-deficient HEK293 cells ([@B14]) indicated that the STT3A-dependent sites in cysteine-rich proteins are located within cysteine-rich protein domains, while sequons located in cysteine-deficient domains show little STT3A dependence. Rapid formation of both native and nonnative disulfides within a cysteine-rich domain will yield protein conformations that are incompatible with insertion of an acceptor site into the peptide-binding pocket of an OST active site, as shown by the x-ray crystal and cryo--electron microscopy structures of eubacterial, archaebacterial and eukaryotic OSTs ([@B31]; [@B34]; [@B72]). Cotranslational scanning of the nascent polypeptide by the mammalian STT3A complex provides a mechanism for N-glycosylation of acceptor sites before disulfides form between nearby cysteine residues.

Metazoan organisms, with the exception of *Caenorhabditi*s species, express both STT3A and STT3B. The *Caenorhabditis elegans* genome does not encode STT3A, DC2, or KCP2. The absence of the STT3A complex in *C. elegans* gives rise to an interesting question concerning the expansion of the glycoproteome. Glycoproteomic analysis of *C. elegans* identified a large number of N-glycosylation sites ([@B76]), including those located within cysteine-rich proteins. Would targeted glycoproteomic analysis indicate that the *C. elegans* cysteine-rich glycoproteins are hypoglycosylated, or are the acceptor sites mainly located in cysteine-deficient domains?

Quantitative glycoproteomic analysis of STT3A(--/--) cells revealed that the STT3A complex is important for glycosylation of sequons with suboptimal flanking sequences ([@B14]). We considered residues between the -2 position and the +3 position relative to the glycosylated asparagine, as there is evidence that flanking sequence residues impact the glycosylation efficiency of NXS sites. The OST has a higher affinity for NXT peptides than for NXS peptides ([@B3]). Glycosylation of NXS sequons is reduced when the +1 position (X residue) has a polar or bulky side chain ([@B53]; [@B32]). To a first approximation, suboptimal sequons can be viewed as NXS sites that have bulky or polar X residues, or NXT/NXS sites that have a proline at the +3 position.

Organisms that express the ER lectins involved in the glycoprotein quality control pathway display strong positive selection for NXT sequons in secretome proteins ([@B16]). Although weaker positive selection is apparent for NXS sequons than for NXT sequons in mammalian glycoproteins, *S. cerevisiae* and *C. elegans* both display negative selection for NXS sites in their glycoproteins. Positive selection for NXS sites in mammalian glycoproteins may reflect an enhanced ability of the translocation channel-associated STT3A complex to glycosylate suboptimal NXS sites. Thus, suboptimal sequons and cysteine-rich glycoproteins represent two examples of how the presence of distinct STT3A and STT3B complexes may have aided expansion of the metazoan glycoproteome by enhancing the modification efficiency of challenging glycosylation sites. In contrast, glycosylation sites in yeast proteins have likely been optimized for efficient glycosylation by an OST complex that does not interact directly with protein translocation channels.

MATERIALS AND METHODS
=====================

Yeast and mammalian expression vectors
--------------------------------------

The yeast expression plasmid pEM497 (pRS316 ppCPY-T7 *URA3*) encoding ppCPY with an appended T7 epitope tag has been described ([@B67]). The plasmid pEM519 (pRS316 ppCPY~+4~-T7 *URA3*) encoding the ppCPY~+4~-T7 derivative that has four mutations in the signal sequence (T5L S6L C9L G10L) has been described ([@B68]). Mammalian expression vectors encoding pSAP-DDKHis ([@B58]) and SHBG ([@B61]) have been described. The plasmid pJW373 encoding unglycosylated CPY (ug-CPY; N124Q, N198Q, N279Q, N479Q) was a generous gift from Jakob R. Winther (University of Copenhagen) ([@B73]).

Recombinant PCR using the pSAP-DDK-His vector and either pEM497 or pEM519 was used to replace the proCPY coding sequence (amino acids \[a.a.\] 19--532) in pEM497 or pEM519 with the prosaposin coding sequence (a.a. 22--527) and the C-terminal DDKHis tag to obtain pSS101 (pRS316 CPY~ss~-pSAP-DDKHis *URA3*) and pSS102 (pRS316 CPY~+4~-pSAP-DDKHis *URA3*). Oligonucleotides encoding asparagine-to-glutamine substitutions were used as primers together with pSS102 in recombinant PCRs to produce pSS103 (pRS316 CPYss-SAPΔ1,2,4 DDKHis *URA3*) and pSS104 (pRS316 CPYss-SAPΔ3,5 DDKHis *URA3*). Recombinant PCR using the mammalian SHBG expression vector and the pEM497 was used to replace the coding sequence for pro-CPY (a.a. 19--532) with the coding sequence for the mature region of SHBG (a.a. 30--402) to obtain plasmid pSS105 (PRS316 CPY~ss~-SHBG URA3). Expression of prosaposin or SHBG in yeast using pSS101-pSS105 was not optimal for very short pulse-labeling experiments. To increase expression, the protein coding sequences and 3′UTR regions were subcloned into a plasmid (pRS416 GDPp *URA3*) containing a glyceraldehyde 3-phosphate dehydrogenase (GPD) promoter (GPDp) to obtain plasmids pSS106-110 (e.g., pSS106 (pRS416 GPDp-CPY~ss~-pSAP-DDKHis *URA3*).

Recombinant PCR using pJW373 encoding unglycosylated CPY and the pSS107 vector (pRS416 GPDp-CPY~+4~-pSAP-DDKHis *URA3*) was used to replace the wild-type CPY coding sequence with the ug-CPY coding sequence to obtain pSS111. Recombinant PCR using the mammalian pSAP-DDKHis expression vector and pJW373 was used to replace the prosaposin coding sequence (a.a. 22--527) with the ug-proCPY coding sequence. Recombinant PCR using oligonucleotides encoding point mutations was used to construct eight additional constructs that contain sets of two or three tandem NXT or NXS sites for expression in yeast or mammalian cells (see diagram in [Figure 5A](#F5){ref-type="fig"}).

Cell culture and transfection
-----------------------------

The HEK293-derived *STT3A(--/--)* cell line was characterized previously ([@B12]). HEK293 cells were cultured at 37°C in 60-mm dishes in DMEM (GIBCO), 10% fetal bovine serum with penicillin (100 U/ml), and streptomycin (100 µg/ml). Cells that were seeded at up to 80% confluency were transfected with reporter plasmids (6 µg) using Lipofectamine 2000 following a protocol from the manufacturer (Invitrogen) and were processed after 24 h. Standard yeast synthetic media containing dextrose (SD), supplemented as noted, were used for growth and transformations ([@B54]).

Antibodies and protein immunoblotting
-------------------------------------

Rabbit polyclonal antibodies to Ost1p ([@B63]), Wbp1p ([@B65]), Swp1p ([@B66]), CPY ([@B62]), and Sec63p ([@B18]) were characterized previously. A goat polyclonal antibody to SHBG (R&D Systems, VFJ01), a mouse monoclonal anti-HA antibody (Roche, 11867423001), and the mouse monoclonal anti-DDK antibody (Sigma, F3165 anti-FLAG M2) were from commercial sources. A mouse monoclonal antibody to *S. cerevisiae* RPL3 (ScRPL3) was obtained from the Developmental Studies Hybridoma Bank at the University of Iowa.

Pulse--chase radiolabeling and immunoprecipitation
--------------------------------------------------

Mammalian cells were pulse or pulse--chase labeled using ^35^S Trans label (Perkin-Elmer) as described previously ([@B61]) using the following pulse and pulse--chase intervals: pSAP, pSAP derivatives, and CPY derivatives, 10 min pulse; SHBG, 5 min pulse, 20 min chase.

Yeast cells that were grown at 30°C in SD media to mid-log phase (0.4--0.6 OD at 600 nm) were collected by centrifugation and resuspended in fresh SD media at a density of 6 A~600~/ml. The yeast cells were allowed to recover for 10 min before pulse-­labeling with Tran-^35^S-label (100 µCi/OD). Pulse labeling at 30°C was for 7 min unless noted otherwise in the figure legends or charts. Radiolabeling experiments were terminated by dilution of the culture with an equal volume of ice-cold 20 mM NaN~3~, followed by freezing in liquid nitrogen. Rapid lysis of cells with glass beads and the immunoprecipitation of the pulse-labeled proteins was done as described ([@B46]) followed by SDS--PAGE to resolve protein glycoforms. As indicated, immunoprecipitated proteins were digested with endoglycosidase H (New England Biolabs). Dry gels were exposed to a phosphor screen (Fujifilm), scanned in Typhoon FLA 9000, and quantified using ImageQuant.

Ribosome-associated membrane protein isolation from yeast microsomes
--------------------------------------------------------------------

A yeast strain (RGY1455; [@B4]) that expresses His~6~-FLAG-Sbh2p was grown at 30°C and used to prepare microsomal membranes as described previously ([@B11]). The membranes were solubilized by 30 min incubation on ice after adjustment to 2% digitonin, 50 mM triethanolamine acetate, pH 7.5 (TEA-OAc), 150 mM KOAc, 5 mM Mg(OAc)~2~. Centrifugation at 100,000 × *g* for 40 min at 4°C yielded a ribosome--membrane protein pellet fraction (P1) and a supernatant fraction (S1). The pellet fraction was resuspended in 50 mM TEA-OAc, 350 mM KOAc, 6 mM Mg(OAc)~2~, and 3 mM Mn(OAc)~2 ~and centrifuged at 100,000 × *g* for 40 min at 4°C to obtain a high salt-washed pellet (P2) and wash fraction (W1). This previous step was repeated to obtain a RAMP and a second wash fraction (W2). The first supernatant fraction (S1) and the two wash fractions (W1 and W2) were combined for protein immunoblot analysis.
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RAMP

:   ribosome-associated membrane protein

RNC

:   ribosome nascent-chain complex
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